Meeder Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.23M | Sell |
26,651
-10,076
| -27% | -$466K | 0.06% | 214 |
|
|
2025
Q1 | $2.24M | Buy |
36,727
+1,882
| +5% | +$115K | 0.13% | 130 |
|
|
2024
Q4 | $1.97M | Buy |
34,845
+7,864
| +29% | +$445K | 0.12% | 128 |
|
|
2024
Q3 | $1.4M | Buy |
26,981
+1,929
| +8% | +$99.8K | 0.09% | 180 |
|
|
2024
Q2 | $1.04M | Buy |
25,052
+4,174
| +20% | +$173K | 0.07% | 214 |
|
|
2024
Q1 | $1.13M | Buy |
20,878
+985
| +5% | +$53.4K | 0.12% | 158 |
|
|
2023
Q4 | $1.02M | Sell |
19,893
-2,265
| -10% | -$116K | 0.12% | 153 |
|
|
2023
Q3 | $1.29M | Sell |
22,158
-6,522
| -23% | -$379K | 0.16% | 108 |
|
|
2023
Q2 | $1.83M | Sell |
28,680
-2,573
| -8% | -$165K | 0.2% | 93 |
|
|
2023
Q1 | $2.17M | Buy |
31,253
+270
| +0.9% | +$18.7K | 0.25% | 72 |
|
|
2022
Q4 | $2.23M | Buy |
+30,983
| New | +$2.23M | 0.28% | 65 |
|